MINI REVIEW
Published on 04 Sep 2026
ctDNA-based detection of residual disease: implications for management of non-metastatic NSCLC
doi 10.3389/fonc.2026.1951454
- 886 views
Articles
SYSTEMATIC REVIEW
Published on 03 Sep 2026
The clinical trial landscape of bispecific antibodies in non-small cell lung cancer: mechanistic trends and developmental strategies
doi 10.3389/fphar.2026.1901850
- 1,480 views
ORIGINAL RESEARCH
Published on 03 Sep 2026
Clinical and genomic characterization of KRAS G13X non-small cell lung carcinoma
doi 10.3389/fonc.2026.1825959
- 891 views
ORIGINAL RESEARCH
Published on 26 Aug 2026
Diagnostic value of peripheral blood leukocyte parameters, NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL, in lung cancer
doi 10.3389/fonc.2026.1793608
- 400 views
ORIGINAL RESEARCH
Published on 19 Aug 2026
Ascomycin enhances the antitumor activity of osimertinib in EGFR-TKI-resistant non-small cell lung cancer
doi 10.3389/fonc.2026.1867321
- 541 views
SYSTEMATIC REVIEW
Published on 31 Jul 2026
Treatment prioritization of chemotherapy-anchored regimens after EGFR-TKI failure in EGFR-mutant NSCLC: a systematic review, pairwise meta-analysis and Bayesian network meta-analysis with probabilistic multi-criteria decision analysis
doi 10.3389/fimmu.2026.1864144
- 1,311 views
REVIEW
Published on 30 Jun 2026
Lung cancer organoids for functional precision oncology: from disease modeling to clinical decision support
doi 10.3389/fonc.2026.1864153
- 1,264 views
CORRECTION
Published on 29 Jun 2026
Correction: Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparison
doi 10.3389/fonc.2026.1883614
- 759 views
ORIGINAL RESEARCH
Published on 26 May 2026
Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients
doi 10.3389/fimmu.2026.1747604
- 1,423 views
ORIGINAL RESEARCH
Published on 21 May 2026
Feasibility of artificial intelligence-based rapid on-site evaluation for the diagnosis of pulmonary disease
doi 10.3389/fonc.2026.1836366
- 1,261 views
- 2 citations
SYSTEMATIC REVIEW
Published on 20 May 2026
Evolution and recent advances in antibody–drug conjugate therapy for lung cancer: a comprehensive systematic review based on the Trialtrove database (inception to July 1, 2025)
doi 10.3389/fonc.2026.1793949
- 4,226 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 May 2026
Real-world effectiveness of first-line immunotherapy with or without chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer
doi 10.3389/fimmu.2026.1753591
- 1,390 views
